Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spectra was a leading global manufacturer of made-to-spec procedural needles, serving as a CDMO for major healthcare companies and OEMs. In late 2024, it acquired XL Precision Technologies to expand its capabilities in precision micro-components. In January 2025, the combined entity rebranded as Elevaris Medical Devices to reflect their unified expertise in medical device development and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spectra Medical Devices.